1 active not recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow CAR T-cells: new trials by email Literature Review of CAR T-cells trials Research Report on CAR T-cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer Chimeric Antigen Receptor T-cells, Cyclophosphamide, Fludarabine - Platinum-Resistant Ovarian Carcinoma | Phase 1 | Recruiting | City of Hope Medical Center | 33 | 2023-05-01 | 2026-08-17 |
| Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy Duvelisib, CAR T-cells - Non-Hodgkin Lymphoma, Acute Lymphocytic Leukemia | Phase 1 | Active not recruiting | Washington University School of Medicine | 42 | 2022-02-28 | 2026-09-24 |
Lymphoma, Non-Hodgkin (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
City of Hope Medical Center (1) · Washington University School of Medicine (1)
United States (2)
Armin Ghobadi, M.D. (1) · Lorna Rodriguez (1)
P30CA033572 (1), R01CA266874 (1)